1/ "The release of the scientists' views caused a furore. Until then, it had not been known how strongly the government's scientific advisors has lobbied for a lockdown in September. The next day Labour backed the scientists & called for a shutdown."
2/ It's a shame this article is behind a paywall, as it highlights critical moments in political #SARSCoV2 decision-making in the UK, & the impact of the false dichotomy that one can either save the economy or lives - rather than that reducing cases does both.
3/ As we've seen time & again in this pandemic, prioritizing actions based on the economy instead of impact on transmission has a tendency to come back to bite: 'back to normal' "now" is so often paid for with hospitalizations, deaths, & more severe restrictions later.
4/ Waiting is also not the answer. Without action, growing cases continue growing. If your skateboard starts accelerating down a hill towards a brick wall, jumping off quick is going to hurt - but it certainly doesn't get less painful the longer you wait. Same with #SARSCoV2.
5/ 'Easy actions' don't necessarily help either. Too often we've seen govts implement rules that avoid the wrath of powerful lobbies, restrict freedoms, & likely have little impact on transmission. 'Restriction theatre' confuses messages & perception about what actions are risky.
6/ 'Restriction theatre' is a bit like dragging your hand on the ground to slow your speeding skateboard, halfway down the hill: It won't work, & now you've also seriously messed up your hand. You've also possibly misled people to believing this is a safe & effective thing to do.
7/ Finally, it's critical to recognise how & by whom government policy is being shaped. In the UK, SAGE & SPI-M (government advice groups) were not always consulted on the measures taken - sometimes they went directly against what they'd advised.
8/ Other times, being 'led by the science' meant meeting with a select group who offered advice that already aligned with govt plans & strategy, rather than a wider consensus. There was no signal to the public that decisions being made weren't backed by SAGE/SPI-M-at-large.
9/ A separate press conference by two chief scientific advisers, & SAGE minutes released ahead of schedule helped shape an important point in the public view: government actions were against prevailing advice, & scientists were deeply concerned.
10/ Scientists can only advise, & it is indeed the weighty burden of politicians to decide how & when to take that advice. It is well within their right to reject it entirely.
But honesty & ownership is needed on both sides: what advice was given, & what govt decision was made.
11/ It is harmful to science /and/ the public for this not to be transparent: trust & blame can be misplaced with long-term consequences. Govts will always claim to be following the science, but the public deserves to fully understand what that means: what science? by whom?
12/ In many ways, all of the above are lessons the UK - & many other countries - are still learning:
- Preserve the economy by reducing cases
- Waiting won't help
- 'Restriction theatre' won't either
- Draw clear lines between science advice given & govt decisions made
13/ It's never too late to take these onboard & embed them in our responses. We still face a long, tough winter ahead with #SARSCoV2#COVID19.
We can make this easier for everyone & save #LivesAndLivelihoods by the actions we take today. Let's get cases down, so we're all safer.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I'm excited to announce a new paper with @MLReichmuth and @C_Althaus, out now in @PLOSPathogens!
We used phylogenetics & modelling to investigate the introduction & expansion of #SARSCoV2 Alpha & Delta variants into #Switzerland & to simulate different interventions.
1/17
First, we wanted to estimate the number of times Alpha & Delta were introduced into Switzerland before they were dominant.
For this we used sequences: we looked for where Swiss Alpha/Delta seqs descend from non-Swiss sequences - coming to Switzerland from elsewhere.
2/17
We looked at two ways of counting these introductions:
Liberal: every Swiss sequence coming from non-Swiss sequences is an introduction
Conservative: only the first Swiss sequence in a subtree of mixed-Swiss-non-Swiss sequences is an introduction
Benevolent dictators have no place in academic science.
I don't care if they usually make the right decision. Or if people don't think they've abused their power yet.
Science should not depend on one person being well-behaved.
Balance should be built in, power distributed.
1/5
"If you want to go fast, go alone, if you want to go far, go together" the African proverb says.
Can driven, visionary people start up groundbreaking ideas & cut through barriers to implement them? Absolutely! This 100% is part of science.
2/5
But if you want your idea to be a keystone of science communities & the public, you have to make it about more than *you*.
If you want to run a private business, go do that.
If you want to be keystone of public science, you have to be transparent, trustworthy, & stable.
3/5
23B (XBB.1.16) is now available on CoVariants! It's visible as part of Per Country & Per Variant plots, on the shared mutation page - and of course, has a page of its own.
As I covered earlier, 23B (XBB.1.16) is descended from the recombinant 22F (XBB) variant, with some additional mutations. You can read more about how it evolved & acquired those mutations below 👇🏻.
Also from this article:
'Marion Koopmans ... says she has received multiple calls from Bogner“with a rather intimidating tone.” So have colleagues, she adds. “I have heard similar experiences from quite a few.”'
And:
"And Science heard many stories about researchers who saw their data curtailed, or cut off, without explanation. Some linked the actions to their being critical of GISAID or being seen as a potential threat."
If you're an early career researcher (yes even 'just' a PhD student!) 1 of my biggest pieces of advice would be:
Go claim/create your Google Scholar page!! 👈🏻✍️🏻
I put this off bc I thought I 'didn't have enough on it'. I also generally thought "nobody is looking for me".
1/4
Now that I'm (a little) on the other end, I see how wrong I was.
It's *just fine* to not have "much" in your Google Scholar profile - anyone worth their salt will be evaluating you relative to your career state.
Much more important: to be findable!
2/4
And alongside that: it's so useful to have an easy way for people to see what your field is & what you've been up to/who you work with/your expertise.
Google Scholar is also pretty easy to maintain (will vary depending on how unique your name is), as it auto-updates.
3/4
23A (XBB.1.5) is now available on CoVariants! It's visible as part of Per Country & Per Variant plots, on the shared mutation page - and of course, has a page of its own.
As I covered earlier, 23A (XBB.1.5) is descended from the recombinant 22F (XBB) variant, with some additional mutations. You can read more about how it evolved & acquired those mutations below 👇🏻.